Akorn Pharmaceuticals files for bankruptcy, closes facilities and will liquidate
The generic drug manufacturer Akorn Pharmaceuticals has filed for bankruptcy and will close its facilities across the US, liquidate its assets and end operations, it …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
